A Human Lin− CD123+ CD127low Population Endowed with ILC Features and Migratory Capabilities Contributes to Immunopathological Hallmarks of Psoriasis by Luz María Mora-Velandia et al.
March 2017 | Volume 8 | Article 1761
Original research
published: 02 March 2017
doi: 10.3389/fimmu.2017.00176
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Heiko Mühl, 
Goethe University Frankfurt, Germany
Reviewed by: 
Marina Cella, 
Washington University 
School of Medicine, USA  
Anja Fuchs, 
Washington University in St. Louis, 
USA
*Correspondence:
Laura C. Bonifaz 
labonifaz@yahoo.com
Specialty section: 
This article was submitted to 
Inflammation, 
a section of the journal 
Frontiers in Immunology
Received: 25 August 2016
Accepted: 07 February 2017
Published: 02 March 2017
Citation: 
Mora-Velandia LM, Castro-
Escamilla O, Méndez AG, Aguilar-
Flores C, Velázquez-Avila M, 
Tussié-Luna MI, Téllez-Sosa J, 
Maldonado-García C, Jurado-
Santacruz F, Ferat-Osorio E, 
Martínez-Barnetche J, Pelayo R 
and Bonifaz LC (2017) A Human 
Lin− CD123+ CD127low Population 
Endowed with ILC Features 
and Migratory Capabilities 
Contributes to Immunopathological 
Hallmarks of Psoriasis. 
Front. Immunol. 8:176. 
doi: 10.3389/fimmu.2017.00176
a human lin− cd123+ cd127low 
Population endowed with ilc 
Features and Migratory capabilities 
contributes to immunopathological 
hallmarks of Psoriasis
Luz María Mora-Velandia1,2, Octavio Castro-Escamilla1,2, Andrés González Méndez1, 
Cristina Aguilar-Flores1, Martha Velázquez-Avila3, María Isabel Tussié-Luna4,5,  
Juan Téllez-Sosa6, César Maldonado-García7, Fermín Jurado-Santacruz7,  
Eduardo Ferat-Osorio1, Jesus Martínez-Barnetche6, Rosana Pelayo3 and  
Laura C. Bonifaz1*
1 Unidad de Investigación Médica en Inmunoquímica Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto 
Mexicano del Seguro Social, Mexico City, Mexico, 2 Universidad Nacional Autónoma de México (UNAM), Mexico City, 
Mexico, 3 Unidad de Investigación en Enfermedades Oncológicas, Hospital de Oncología, Centro Médico Nacional ‘Siglo 
XXI’, Mexico City, Mexico, 4 División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México 
(UNAM), Mexico City, Mexico, 5 Unidad de Investigación en Virología y Cáncer, Hospital Infantil de México “Federico Gómez”, 
Mexico City, Mexico, 6 Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, 
Cuernavaca, Morelos, Mexico, 7 Centro Dermatológico “Dr. Ladislao de la Pascua”, Secretaria de Salud de la Ciudad de 
México, Mexico City, Mexico
Innate lymphoid cells (ILC) are members of a heterogeneous family with a lymphoid 
origin that mimics the T helper (Th) cytokine profile. ILC are involved in early effector 
cytokine-mediated responses during infections in peripheral tissues. ILC also play an 
important role in chronic skin inflammatory diseases, including psoriasis. Although clas-
sical ILC express CD127, it has been recently reported that the presence of non-classical 
CD127− ILC populations and an early ILC precursor (EILP) CD127low. ILC development 
has predominately been investigated in mouse models. However, in humans, different 
transcription factors have been described for ILC identification. NFIL3 (nuclear factor, 
IL-3 regulated) is crucial for ILC development in response to IL-7. CD123 (IL-3Rα) is 
usually used to exclude basophils during ILC identification, however, it is unknown if 
in response to IL-3, NFIL3 could be relevant to induce ILC features in Lin− CD123+ 
populations in addition, is also unknown whether peripheral blood (PB) population with 
ILC features may have skin-homing potential to participate in skin inflammatory chronic 
diseases. Here, we report a Lin− CD123+ CD127low CD7+ CLA+ population that share 
some phenotypic properties with basophils, but expresses several transcription factors 
Abbreviations: AhR, aryl hydrocarbon receptor; BCR, B cell receptor; BDCA, blood dendritic cell antigen; cDC, conventional 
dendritic cells; CLA, cutaneous lymphocyte antigen; CLP, common lymphoid precursor; CRTH2, chemoattractant receptor-
homologous molecule expressed on Th2 cells or prostaglandin D2 receptor 2; CS, control skin; GATA-3, trans-acting T-cell-
specific transcription factor; HD, healthy donors; HLA-DR, human leukocyte antigen-antigen D related; HUVEC, human 
umbilical vein endothelial cells; ILC, innate lymphoid cells; NCR, natural cytotoxicity receptors; NFIL3, nuclear factor, IL-3 
regulated; NK, natural killer; PB, peripheral blood; PBMCs, peripheral blood mononuclear cells; pDCs, plasmacytoid dendritic 
cells; PLZF, promyelocytic leukemia zinc finger; PMA, phorbol 12-myristate 13-acetate; ROR-γt, RAR-related orphan receptor 
gamma; SDF-1, stromal cell-derived factor-1; T-bet, T-box transcription factor; TCR, T cell receptor; TCF-1, T cell factor-1; 
Th, T helper; TOX, thymocyte selection-associated high-mobility group box protein.
2Mora-Velandia et al. CD123+ Population with ILC Features
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 176
inTrOdUcTiOn
Innate lymphoid cells (ILC) have been defined as a heterogene-
ous family derived from a CD7+ common lymphoid precursor 
(CLP) (1–3). During the previous decade, several ILC popula-
tions that participate in the defense against pathogens and 
inflammatory diseases have been described mainly in mice (4, 
5). The identification of ILC populations in humans, as well as 
their role in disease pathogenesis, comprises a topic of extensive 
investigation.
Several groups have used distinct criteria and markers for ILC 
identification. ILC have a classical lymphoid morphology; they 
lack T cell receptor or BCR expression and are considered lineage 
negative (Lin−) cells. In humans, the most common lineage mark-
ers include CD3, CD19 (for T and B cells), CD14 (monocytes), 
and CD11c, as well as blood dendritic cell antigen (BDCA)-1, 
-2 (dendritic cells). CD123 expression has been used to exclude 
plasmacytoid dendritic cells (pDCs) and basophils, while FcεR 
for basophils and mast cells (6, 7).
Classical ILC in human peripheral blood (PB) express CD127. 
However, a non-classical category of ILC CD127− (8) as well as 
an early ILC precursor (EILP) CD127low (9) has been recently 
reported. In addition to CD127, other markers have been used 
in human PB for ILC identification, ILC express CD132 (γ com-
mon chain), which is crucial for development, as well as CD90 
and CD161 as ILC markers (2). The expression of α4β7 integrin 
has been reported in ILC precursors in mice (10–12). In addi-
tion to surface markers, several transcription factors have been 
used for ILC identification. The transcription factor inhibitor of 
DNA binding 2 (Id2) is essential for identification and linage 
commitment (13, 14). In addition to Id2, transcriptional factors, 
such as thymocyte selection-associated high-mobility group box 
protein (TOX) and promyelocytic leukemia zinc finger (PLZF), 
have been described as essential for ILC development (15–17); in 
humans, these additional transcriptional factors have primarily 
been used as ILC lineage-related markers. Recently, T cell fac-
tor-1 (TCF-1) has been also described in mice as crucial for ILC 
development (18). Remarkably, it has been demonstrated that the 
nuclear factor, IL-3 regulated (NFIL3) is a crucial transcription 
factor in ILC development in response to IL-7 (19). Although 
CD123 (IL-3Rα) is usually used to exclude basophils and mast 
cells during ILC identification, it is unknown if in response to 
IL-3, NFIL3 might be relevant to induce ILC features in Lin− 
CD123+ populations.
Based on the criteria used to identify ILC in mice, three main 
groups of ILC have been described and identified in humans (2, 
20) as CD161+. In addition, ILC1 are c-Kit− and CRTH2− and 
express T-bet and IFN-γ, while ILC2 are c-Kit+ and CRTH2+ 
and express GATA-3, IL-4, IL-5, and IL-13, and ILC3 are c-Kit+, 
CRTH2− are AhR+ (aryl hydrocarbon receptor), IL23R+ CCR6+ 
and express RORγt, IL-17, and IL-22 (6, 21, 22). ILC3 may also 
express natural killer (NK) receptors such as NKp44 (22, 23). 
It has been proposed that ILC mimic the effector function of T 
helper (Th) lymphocytes (Th1, Th2, and Th17). However, ILC 
activation is mainly mediated by cytokines expressed by other 
innate cells, such as dendritic cells, macrophages, or stromal cells 
(24, 25). In general, the most frequent in vitro conditions used 
to resemble the in vivo activation include the use of IL-12 and 
IL-15 or IL-18 for ILC1, IL-25, IL-33, and TSLP for ILC2 and 
IL-1β, IL-2 and IL-23 for ILC3 and, in some cases, the presence 
of IL-7 (26).
As a result of the increasing numbers of ILC studies, it has 
been possible to establish the presence and diversity of classical 
and, to a less extent, non-classical ILC populations in different 
peripheral tissues (27); mouse models have demonstrated that 
ILC together with other innate cells are the first line of defense 
for ILC commitment such as inhibitor of DNA binding 2 (Id2), NFIL3, promyelocytic 
leukemia zinc finger (PLZF), thymocyte selection-associated high-mobility group box 
protein (TOX), and T cell factor-1 (TCF-1). In addition, this population expresses different 
ILC markers: CD132, CD90, CD161, α4 integrin, c-Kit, CRTH2, AhR, and IL-23R. IL-3 
prevents apoptosis and increases their NFIL3, TOX, and PLZF expression. In PB, the 
CD123+ CD127low population is predominantly a conspicuous population that expresses 
T-bet and RORγt. The Lin− CD123+ CD127low population in PB has a limited Th type 
cytokine expression and highly expresses IL-8. The Lin− CD123+ CD127low population 
expresses skin-homing receptors (cutaneous lymphocyte antigen and CXCR4) and 
transmigrates through endothelial cells in response to SDF-1. An equivalent Lin− 
CD123low population was identified in control skin, which shows a broader phenotypic 
diversity and cytokine production, including IL-22 and IL-17. Remarkably, the CD123low 
population in the lesion and non-lesion skin of psoriasis patients expresses IL-17 and 
IL-22. Our findings suggest the identification of an alternative Lin− CD123+ CD127low 
population with ILC features endowed with migratory capabilities that might contribute 
to immunopathological hallmarks of psoriasis.
Keywords: innate lymphoid cells, psoriasis, il-3rα, il-17, sdF-1, cXcr4 axis, skin inflammation
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against pathogens (28–31). Recently, a regulatory role for ILC 
populations have been reported (32). Therefore, in humans, there 
is increasing evidence that ILC play a role in several pathologies, 
such as allergies and chronic inflammatory skin disorders (33), 
including psoriasis (34, 35). Interestingly, the proportions of the 
different subsets (ILC1, ILC2, and ILC3) among tissues appear to 
be different, and it also appears that the local microenvironment 
may influence the “specialized” functions of ILC (36, 37). It has 
been proposed that ILC in PB may represent a reservoir of ILC in 
which their functional features may be distinct from peripheral 
tissues (7, 24, 38). Nevertheless, the mechanisms that underlie 
the migration of ILC into different tissues under steady state or 
inflammatory conditions are in the early stages of investigation. 
In particular, for skin migration, it has been reported that in PB, 
ILC2 and ILC3 express cutaneous lymphocyte antigen (CLA) (39, 
40), which is the main assumed mechanism of ILC skin tropism 
under steady-state conditions; however, additional migration 
mechanisms under inflammatory conditions have not been 
established to date.
In the skin, one of the main human pathologies in which 
the participation of ILC has been investigated is psoriasis. It 
has been described that blood and skin samples from patients 
have increased ILC3 NCR+ frequencies (40, 41), and although 
the IL-22-producing ILC3 had been well identified, the pro-
duction of IL-17 has been reported in lymphoid CD3− cells. 
These findings suggest that in the skin, other cell populations 
(Lin− CD45+ CD3−) exist that produce IL-17. Nevertheless, it 
has not been well established whether these cells are related to 
the ILC lineage.
Here, we identified a Lin− CD123+ CD127low population in 
the PB of healthy donors (HD) that express several ILC features 
and in which IL-3 appears to be essential for their maintenance 
and identity. Interestingly, this Lin− CD123+ CD127low popula-
tion highly expresses CLA and exhibits migratory potential 
in response to SDF-1. Remarkably, a similar Lin− CD123low 
population was identified in control skin (CS) and importantly 
in psoriasis skin (PS) biopsies with the capability to express IL-22 
and IL-17. These findings suggest that this population with ILC 
features may contribute to the immunopathological features of 
psoriasis.
MaTerials and MeThOds
Blood sample collection
Buffy coats of HD were obtained from the Blood Bank from the 
“Hospital Infantil de México: Federico Gómez.” Peripheral blood 
mononuclear cells (PBMCs) were isolated with Lymphoprep 
(Axis-Shield, Oslo, Norway) from buffy coats.
skin Biopsies from cs and Psoriasis 
Patients
Control skin was obtained from remnant skin following plastic or 
abdominal surgeries that was free from dermatologic pathologies 
from the “Hospital de Especialidades Dr. Bernardo Sepulveda 
CMN Siglo XXI.” Patients were recruited from the dermatology 
clinic of the Centro Dermatológico Dr. Ladislao de la Pascua. 
Fifteen patients who fulfilled the diagnostic criteria for psoriasis 
in plaque were included in this study prior to treatment initiation. 
Patient biopsies were obtained with a 5–6 mm punch.
skin cell collection
Skin samples were placed overnight in RPMI medium and 
dispase II (Grade II protease, Roche, Switzerland). The dermis 
was then mechanically separated from the epidermis. Dermal 
cells were obtained by allowing migration from dermal seg-
ments placed in culture in RPMI medium for 7  days. The 
collected cells were used for activation experiments, and the 
cell supernatants were used as chemoattractant stimuli in 
migration assays.
Flow cytometry analysis and sorting
In order to block Fc receptors, PBMCs were incubated with an 
in-house-made buffer containing 2% horse serum. Cells were 
stained with a cocktail of antibodies (complete list included in 
Supplementary Material). Fixation was performed using 4% 
paraformaldehyde (PFA). All antibodies were isotype-matched 
with their respective fluorophore. Intracellular assessment of 
cytokines and transcriptional factors were performed using 
Cytofix/Cytoperm (BD Biosciences, San Jose, CA, USA) or the 
Factor Fixation and Permeabilization Buffer Set (Biolegend, 
San Diego, CA, USA), respectively. Cells were incubated with 
antibodies for 30 min at room temperature. Before cell fixation, 
Hoechst 33342 staining assessed cell viability during assays. The 
samples were acquired using a FACS Canto (BD Biosciences, San 
Jose, CA, USA) and were analyzed with Flowjo software (Tree 
Star). For cell isolation, PBMCs were stained with PE-conjugated 
lineage marker antibodies. Lineage+ cells (CD3+, CD14+, CD19+, 
CD94+, and HLA-DR+) were depleted using anti-PE Microbeads 
and LD columns (Miltenyi-Biotec, BG, Germany). The cells were 
sorted from the lymphoid region and according to CD123 and 
CD127 expression using a FACS Aria II (BD Biosciences, San 
Jose, CA, USA).
Heat Map Construction
The median fluorescence intensities (MFs) were determined for 
each cell surface marker and each subpopulation; the minimum 
value reported (gray) corresponds to the isotype control (MF), 
and the maximum value reported (red) corresponds to the cell 
population with the highest MF value.
Imaging Flow Cytometry
The morphology of total pre-enriched Lin− CD123+ cells was 
evaluated in PBMCs previous to depletion of Lineage+ cells (as 
described above) and stained with anti-CD123 and the nuclear 
dye DAPI (Thermo Fisher Scientific, MA, USA). Cells were 
acquired using the Amnis ImageStream Mark II and analyzed by 
the IDEAS® software (Merck-Millipore, MA, USA).
Quantitative rT-Pcr
Total RNA was extracted from a pool of three different cell 
donors using RNeasy Mini Kit (Qiagen, Hilden, Germany), 
and cDNA was synthesized using Maxima First Strand cDNA 
Synthesis kit (Thermo Fisher Scientific, MA, USA), according 
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to the manufacturer’s instructions. Quantitative gene expres-
sion for human IL7Rα or for the housekeeping human GAPDH 
gene was performed using Maxima Syber Green qPCR Master 
Mix (Thermo Fisher Scientific, MA, USA) and a Rotorgene Real 
Time PCR System (Qiagen, Hilden, Germany). Used primers: 
IL7Rα-Forward: 5′ AGG ATG AAA ACA AAT GGA CGC A 3′. 
IL7Rα-Reverse: 5′ CCT TTA AAA TAG TGA TCA GGG ATG G 
3′. Size of cDNA product: 238 bp.
incomplete dh–Jh rearrangements 
analysis
Genomic DNA was extracted from sorted cell populations 
using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). 
The identification of incomplete DH–JH rearrangements was 
performed using the BIOMED-2 primer sets as described (42). 
Briefly, two independent PCR reactions per DNA sample were 
set: a multiplexed PCR reaction combining a single JH consensus 
primer and six DH primers (Tube D) corresponding to six of the 
seven DH segment families. The second reaction contained the 
same JH primer and a single DH7 primer (Tube E). Each reac-
tion product was subjected to capillary electrophoresis using the 
Agilent DNA 1000 chip in the Agilent 2100 Bioanalyzer system.
cell activation
Peripheral blood mononuclear cells or skin cells were stimulated 
using the cell stimulation cocktail and the protein transport inhibi-
tion cocktail (for the last 6 h of culture) (eBioscience-Affymetrix, 
Santa Clara, CA, USA) to assess the production of cytokines 
via intracellular staining. When indicated, IL-3 was added to 
the culture for 18  h to evaluate the phenotype and expression 
of transcriptional factors. Furthermore, ILC1, ILC2, and ILC3 
cocktails (Supplementary Material) were added to the culture for 
18 h to determine the expression of intracellular cytokines; IL-3 
and IL-7 were included in all cocktails.
IgE Crosslinking Assay
Peripheral blood mononuclear cells were incubated with 1 µg/mL 
of human IgE (Merck-Millipore, MA, USA) during 2 h, washed, 
and incubated with 2 µg/mL of anti-human IgE (BD Biosciences, 
San Jose, CA, USA) during 30  min; the activation of cells was 
assessed by the expression of phenotypic markers at the end of 
incubation.
immunofluorescence
Goat anti-Id2 (R&D Systems, Minneapolis, MN, USA), Biotin 
anti-goat IgG, Isotype control, AlexaFluor 488 Streptavidin 
(Jackson-lmmunoresearch, West Grove, CA, USA) and 
Vectashield-DAPI (Vector-laboratories, Burlingame, CA, USA) 
were used to stain sorted populations. Images were acquired using 
a Leica TCS SP8x Confocal Microscope (Wetzlar, Germany) and 
were analyzed with Leica software.
cell Viability assay
Isolated Lin− CD123+ CD127low cells were cultured in the pres-
ence or absence of IL-3 (PeproTech, NJ, USA) for 3 days. Cells 
were collected and stained using the FITC Annexin V Apoptosis 
Detection Kit (BD Biosciences, San Jose, CA, USA) according 
to the manufacturer’s instructions. Samples were acquired using 
a FACS Canto (BD Biosciences, San Jose, CA, USA) and were 
analyzed with Flowjo software (Tree Star).
cytokine Quantification
Isolated Lin− CD123+ CD127low from the lymphoid region or 
Lin− CD127+ cells were cultured in the presence or absence of 
IL-3 (PeproTech, NJ, USA) for 18 h ± stimulation cocktail (eBio-
science-Affymetrix, Santa Clara, CA, USA) during the last 6 h of 
culture. The supernatants were collected and stored (−80°C) until 
analysis. The quantification was performed using a personalized 
(Supplementary Material) Magnetic Luminex Screening Assay 
(R&D Systems, Minneapolis, MN, USA). Sample acquisition and 
analysis were performed in a MagPix instrument (Luminex, TX, 
USA).
Migration assay in Transwell system
Using a transwell system (Corning, NY, USA), migration in 
response to stimuli, SDF-1 (R&D systems, Minneapolis, MN, 
USA) or supernatants from CS or PS cell cultures was assessed 
after 3 h. Migration was also assessed in the presence of blocking 
anti-CXCR4 (Biolegend, San Diego, CA, USA). The transmigra-
tion assays using endothelial cells, the upper chamber of the 
transwell was covered with attachment factor (Gibco, Thermo 
Scientific, MA, USA) during 1  h/37°. Human umbilical vein 
endothelial cells were cultured for 1–2 days (with supplemented 
EGM-2 medium, Lonza, Switzerland) in the previous covered 
well to promote monolayer formation. The monolayer was 
subsequently washed with PBS 1× and used for the migration 
assay. 2 ×  106 PBMCs per milliliter were placed in the upper 
chamber in the presence or absence of SDF-1 as stimuli to assess 
migration after 4 h. Cells from the upper and lower chambers 
were counted using a microscope and were analyzed by flow 
cytometry.
statistical analysis
Statistical analysis was performed using the GraphPad Prism 
5.0 (La Jolla, CA, USA) software. The non-parametric Mann–
Whitney U test was used to calculate the statistical significance 
between the groups. All p values less than 0.05 were considered 
statistically significant.
resUlTs
a human lin− cd123+ cd127low cell 
Population with lymphoid and Basophil 
Features in PB
To determine the presence of Lin− CD123+ (IL-3Rα) population 
in the PB of HD, cells with a lymphoid morphology and linage 
negative (Lin−) for T cells (CD3−), B cells (CD19−), monocytes 
(CD14−), NK cells (CD94−), and dendritic cells (HLA-DR−) were 
evaluated. Two distinct Lin− cell populations were identified: the 
classical CD127+ population and a CD123+ with low expression 
of CD127 by both, flow cytometry and PCR (Figures  1A,B). 
The cell frequency of the CD123+ CD127low population is 
approximately 0.7–1.4%, while the CD127+ population is 
FigUre 1 | a human lin− cd123+ cd127low population with lymphoid and basophil features in peripheral blood. (a) From left to right: gate analysis on 
lymphoid cells, exclusion of lineage positive cells and identification of Lin− CD123+ and Lin− CD127+ populations. Cell frequencies (%) data represent the media 
values from 30 human blood samples. (B) Lin− CD123+ (isolated from the lymphoid region and gated as shown in Figure S1A in Supplementary Material) and T 
lymphocytes purified from a pool of three human blood samples by cell sorting were assessed for the expression of IL7Rα by quantitative RT-PCR. The monocyte 
cell line THP1 was used as negative control. Relative expression was normalized to GAPDH gene expression values. (c,d) Heat maps, representative of three 
independent experiments, are shown. Median fluorescence intensity (MF) values for the exclusion of additional lineage and dendritic cell markers, respectively. 
Color-coded scale is shown under the heat map from minimum (isotype) to maximum values. pDCs, plasmacytoid dendritic cells; cDCs, conventional dendritic cells. 
(e) Imaging flow cytometry analysis of total pre-enriched Lin− CD123+ cells. The graph at the left shows CD123 expression vs. lobe count that categorizes enriched 
Lin− CD123+ cells in to two populations: yellow: non-lobed cells and pink: lobed cells. At the right, the morphology of each population is shown (50 cells of each 
population were analyzed). (F,g) Compared cell analysis with two different gating strategies. (F) Lin− CD123+ and further FSC vs. SSC, or (g,h) FSC vs. SSC 
followed by Lin− vs. CD123+ gating. Both gating strategies showed the identification of two cell populations as FSCint SSCint (1) and FSClow SSClow (2) with a 
frequency of 0.3–1.1% and 0.7–1.3%, respectively, within total peripheral blood mononuclear cells (cell frequencies (%) represent media values of 10 human blood 
samples). (h) Basophil markers expression in both populations [gated as in panel (g)]. (i,J) CD127 and CD7 compared expression in different cell populations. Red: 
Lin− CD123+ (FSCint SSCint), blue: Lin− CD123+ (FSClow SSClow) [gated as in panel (g)], purple: Lin− CD127+, green: monocytes, white: isotype for each cell 
population. MF values representative of three independent experiments are presented.
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approximately 0.09–0.15% of the total PBMC cells. The CD123+ 
CD127low population is about 8–10 times more frequent than 
the CD127+ population (Figure 1A). As indicated in Figure 1C, 
both the Lin− CD123+ CD127low and CD127+ populations are 
negative for CD34, suggesting that they are not primitive 
precursor cells, as well as for T cells (TCRαβ), granulocytes 
(IL-5R, CD177, and CD66) and NK, monocytes, and neutrophil 
(CD16). The Lin− CD123+ CD127low was also negative for con-
ventional dendritic cells (BDCA-1, BDCA-3, and CD11c) and 
pDCs (BDCA-2, BDCA-4, and HLA-DR) (Figure  1D; Figure 
S1 in Supplementary Material). As indicated in Figure S1 in 
Supplementary Material, the Lin− CD123+ CD127low population 
was absent when anti-FcεR was included in the linage cocktail. 
Therefore, in addition to CD123, we evaluated its morphology 
and expression of basophil markers, including FcεR, CCR3, 
CD203c, and an antigen expressed in the secretory granules of 
human basophils that is recognized by the monoclonal antibody 
2D7 (43). Remarkably, imaging flow cytometry assay identified 
two populations of total pre-enriched Lin− CD123+. As observed 
in Figure  1E, there is a mixture of lymphocyte cells with not 
segmented nuclei (no lobes), and cells with a classical basophil 
morphology (lobed nuclei). In addition, two cell populations by 
two different gating strategies were identified when Lin− CD123+ 
and then FSC vs. SSC were analyzed (Figure 1F) or upon FSC 
6Mora-Velandia et al. CD123+ Population with ILC Features
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vs. SSC and then Lin− vs. CD123+ analysis (Figure 1G). These 
two cell populations were further defined as FSCint SSCint (1) 
and FSClow SSClow (2) with a frequency of 0.3–1.1 and 0.7–1.3%, 
within total PBMCs, respectively. Both populations showed 
similar expression of FcεR and CCR3. However, the expression 
of CD203c and the antigen identified by the 2D7 mAb are sub-
stantially lower in the CD123+ CD127low population from the 
lymphoid region, consistent with its morphology (Figure 1H). 
To evaluate the possible lymphoid origin of the Lin− CD123+ 
CD127low, we investigated the presence of incomplete DH–JH 
rearrangements as a molecular fingerprint of early lymphoid 
precursors. As shown in Figures S2 and S3 in Supplementary 
Material, we could not find significant DH-JH rearrangements 
in the CD127+ classical ILC or in the Lin− CD123+ CD127low 
population when compared with B-lymphocytes and acute B cell 
leukemia cell line NAL-M6. However, the expression of CD7 dis-
tinguished the lymphoid-related CD123+ cells from the CD123+ 
FSCint SSCint population and monocytes (Figures  1I,J). These 
findings indicate the presence of two Lin− CD123+ populations 
in PB and suggest that CD123+ CD127low cells express a mixture 
of basophil and lymphoid features.
a human lin− cd123+ cd127low cla+ 
Population with ilc Features in PB
Several ILC markers were investigated in the Lin− CD123+ 
CD127low within the lymphoid region. Importantly, such popula-
tion expressed high levels of CD132 and CD90, compared to the 
Lin− CD127+ population, but low levels of CD161 (Figure 2A). 
In addition, both populations were similar in the low expression 
of α4 integrin that has been reported in ILC precursors. Higher 
levels of c-Kit and CRTH2, AhR and IL23R were observed in 
the Lin− CD123+ CD127low when compared to the Lin− CD127+ 
counterpart, but both populations were NKp44−. Although 
both populations displayed similar amounts of CCR6, the Lin− 
CD123+ CD127low population exhibited a remarkable expression 
of CXCR4 and of the CLA (Figure 2A).
In addition, the transcriptional factor Id2, which is crucial 
for ILC commitment, was confirmed in these cells. Notably, the 
Lin− CD123+ CD127low and CD127+ populations express Id2 
predominantly within nuclei compared to the isotype control, 
although the staining pattern was distinct (Figures 2B–F).
identity and Maintenance of the ilc 
Features in the lin− cd123+ cd127low 
Population are Mediated by il-3
Next, the effect of IL-3 was assessed in the Lin− CD123+ 
CD127low population. Sorted Lin− CD123+ CD127low from the 
lymphoid region cells were cultured in the presence of IL-3; after 
3 days, IL-3 enabled the survival of the cells, as more than 90% of 
the cells cultured without IL-3 died via apoptosis (Figure 3A). 
In addition to Id2 NFIL3, PLZF, TOX, and TCF-1 have been 
reported as crucial in ILC development (15–17). Notably, the 
Lin− CD123+ CD127low population expressed similar levels of 
NFIL3 compared with the classic CD127+ ILC; however, the 
CD127+ population exhibited a higher expression of PLZF, 
TOX, and TCF-1. Remarkably, IL-3 was capable of increasing 
the expression of NFIL3, PLZF, and TOX in the Lin− CD123+ 
CD127low population in contrast to the CD127+ population 
(Figures 3B–E). These findings suggest that IL-3 has two main 
roles in the CD123+ CD127low population: maintenance of cell 
survival and the upregulation of crucial transcriptional factors 
related to ILC identity.
The lin− cd123+ cd127low Population is 
Primarily a conspicuous Population That 
expresses T-bet and rOrγt
Innate lymphoid cells populations are classified by phenotype in 
ILC1, ILC2, and ILC3 (44). In this regard, we determined that 
the majority of cells within the Lin− CD123+ CD127low popula-
tion displayed a phenotype similar to ILC2, due to expression of 
CD161low, c-Kit, and CRTH2, although expression of CRTH2 may 
resemble a basophil-like phenotype. In contrast, a limited number 
of cells with an ILC1 (CRTH2−, c-Kit−) or ILC3 (CRTH2−, c-Kit+, 
NKp44−) phenotype were identified (Figure 4A). In contrast, in 
the CD127+ ILC, we identified two populations by the expression 
of CD161, and ILC1, ILC2, and ILC3 (NKp44) populations were 
identified (Figure 4B). Remarkably, the Lin− CD123+ CD127low 
population had similar expressions of T-bet and RORγt com-
pared with the CD127+ population; however, there was only a 
slight expression of GATA-3 (Figure 4C). The small amount of 
diversity and the expression of T-bet, RORγt, or GATA were not 
affected in the Lin− CD123+ CD127low population by IL-3 culture 
(data not shown). These findings indicated that the Lin− CD123+ 
CD127low population in PB is primarily a conspicuous popula-
tion with minority phenotypic diversity that expresses T-bet and 
RORγt, which suggests that these transcription factors may be 
involved in their function.
steady-state Peripheral lin− cd123+ 
cd127low Population expresses limited Th 
Type cytokine Variety
The ILC1, 2, and 3 populations have been described as innate 
analogs to Th lymphocytes by their capacity to express cytokines 
(28, 45). Therefore, to determine the Th type cytokine produc-
tion of the Lin− CD123+ CD127low population, the expression 
of intracellular cytokines in activated PBMCs was assessed. The 
Lin− CD123+ CD127low population expresses IFN-γ, IL-2, and 
IL-4 after PMA/Ionomycin activation (Figure 5A). Of note, the 
population that mainly expresses the cytokines downregulates 
CD123. The cytokine expression pattern was similar in the 
classic CD127+ ILC population (Figure  5B). Remarkably, the 
expression of IL-17 or IL-22 was not identified in the PB Lin− 
CD123+ CD127low population, and only a minor percentage of 
IL-22+ in the CD127+ ILC was identified. Considering that it has 
been reported that ILC may be activated by cytokines, PBMCs 
were cultured with cytokine cocktails for ILC1, ILC2, or ILC3 
activation. Figures 5C,D indicate that IFN-γ is expressed in the 
Lin− CD123+ CD127low and CD127+ populations after culture 
with IL-12 and IL-15. The percentage of IFN-γ+ cells is similar in 
both populations; however, the expression of IFN-γ is increased 
in the CD127+ compared with the Lin− CD123+ CD127low ILC 
FigUre 2 | a human lin− cd123+ cd127low cla+ population with innate lymphoid cells (ilc) features in peripheral blood. (a) Compared expression of 
multiple ILC markers in the Lin− CD123+ CD127low and Lin− CD127+ populations: black: Lin− CD123+, gray: Lin− CD127+, and white: isotype. Median fluorescence 
intensity values representative of three independent experiments are shown. (B) Inhibitor of DNA binding 2 (Id2) expression in sorted Lin− CD123+ from the lymphoid 
region (gated as shown in Figure S1A in Supplementary Material) (c) isotype and (d) Lin− CD127+ cells, (e) isotype, immunofluorescence staining for Id2 (green) and 
DAPI (nucleus staining), n = 10. (F) Nuclear median fluorescence intensity in Lin− CD123+ and Lin− CD127+ compared with the isotype control (***p < 0.0001).
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population. The culture with the ILC2 cocktail (IL-33 and IL-2) 
did not induce the expression of ILC2 type cytokines, such as IL-4 
or IL-13, and the culture with the ILC3 cocktail (IL-1β, IL-2, and 
IL-23) did not induce the expression of ILC3 type cytokines, such 
as IL-17 or IL-22 (Figure S3 in Supplementary Material). These 
findings indicate that the steady-state peripheral Lin− CD123+ 
CD127low population expresses limited Th type cytokine variety.
The lin− cd123+ cd127low Population in 
PB expresses high levels of il-8
We subsequently isolated the Lin− CD123+ CD127low popula-
tion from the lymphoid region and CD127+ ILC population 
to evaluate the cytokines in the supernatants via a multiplex 
assay after activation. Surprisingly, the Lin− CD123+ CD127low 
population produced high levels of IL-8 and low levels of IL-4 
(Figure  6A), whereas the CD127+ expressed IL-8 and IL-2; 
however, other Th type cytokines were not identified in the 
purified populations (data not shown). The high expression of 
IL-8 by the CD123+ CD127low population was confirmed via 
intracellular detection in which IL-3 induced the expression 
of IL-8 (Figure 6C), which was significantly increased in the 
presence of PMA/Ionomycin (Figures  6B,C). The percentage 
of IL-8+ cells was significantly increased in the Lin− CD123+ 
CD127low cells compared with the CD127+ ILC (Figures 6B,C). 
The lack of expression of IL-2 and IFN-γ in the isolated Lin− 
CD123+ CD127low population was also confirmed via intracel-
lular detection, in which only the expressions of IL-4 and IL-8 
(Figure 6D, lower panel) and not IL-2 or IFN-γ were identified 
(Figure  6D, upper panel). These findings indicate that the 
freshly isolated steady-state Lin− CD123+ CD127low population 
expresses high levels of IL-8 and confirm the limited expression 
of Th type cytokines.
FigUre 4 | The lin− cd123+ cd127low population is primarily a 
conspicuous population that expresses T-bet and rOrγt. (a) 
Classification of innate lymphoid cell (ILC) subpopulations (from total 
peripheral blood mononuclear cells): gated on: CD161+ cells; ILC1 (CRTH2−, 
c-Kit−), ILC2 (CRTH2+), and ILC3 (CRTH2−, c-Kit+) subpopulations within the 
Lin− CD123+ (a) and Lin− CD127+ (B) populations. Dot plots are 
representative of at least three independent experiments. (c) T-bet, GATA-3, 
and ROR-γt expression on Lin− CD123+ and Lin− CD127+ populations: black: 
Lin− CD123+, gray: Lin− CD127+, and dotted: isotype. Median fluorescence 
intensity values representative of three independent experiments are 
presented.
FigUre 3 | identity and maintenance of the innate lymphoid cell 
features in the lin− cd123+ cd127low population are mediated by il-3. 
(a) Viability assay with sorted Lin− CD123+ cells (from the lymphoid region, 
gated as shown in Figure S1A in Supplementary Material) cultured ± IL-3 for 
3 days. The percentages of dead and viable cells are shown. Dot plots are 
representative of three independent experiments. (B–e) Comparison of 
NFIL3, promyelocytic leukemia zinc finger (PLZF), thymocyte selection-
associated high-mobility group box protein (TOX), and TCF-1 expression in 
Lin− CD123+ and Lin− CD127+ populations (from total peripheral blood 
mononuclear cells): black: +IL-3 (18 h), gray: non-stimulated, and dotted: 
isotype. Median fluorescence intensity values representative of three 
experiments are shown.
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The lin− cd123+ cd127low cla+ Population 
has Migratory Potential Mediated by 
sdF-1
Considering the high display of CLA in the Lin− CD123+ 
CD127low population, the expression of other homing recep-
tors was subsequently assessed. Figure 7A indicates that the 
Lin− CD123+ CD127low population exhibited an increased 
expression of CXCR4 and CD62L compared with the CD127+ 
ILC. In contrast, we identified an increased expression of 
CCR6 in the CD127+ ILC compared with the Lin− CD123+ 
CD127low cells (Figure  7A). The Lin− CD123+ CD127low 
population from PB highly expresses CXCR4; thus, migration 
assays were performed with SDF-1, the ligand for CXCR4. As 
indicated in Figure 7B, the Lin− CD123+ CD127low population 
from PB migrates in response to SDF-1. In addition, SDF-1 
is present in the skin culture supernatants from CS, and a 
significant increase in SDF-1 was identified in the inflamed 
skin cultures obtained from the biopsies of patients with 
psoriasis (Figure  7C). Remarkably, a significantly increased 
migration in response to supernatants obtained from cell 
cultures from PS lesion biopsies was dependent on CXCR4-
SDF-1 compared with supernatants from the CS (Figure 7D). 
In addition, the Lin− CD123+ CD127low but not the CD127+ 
population transmigrated through activated endothelial, 
and this migration significantly increased in response to 
SDF-1 (Figure 7E). Interestingly, the Lin− CD123+ CD127low 
population increased the expression of CD127 after contact 
with activated endothelial cells (Figure S5 in Supplementary 
Material). These findings indicate the high migratory capabil-
ity of the Lin− CD123+ CD127low CLA+ population and suggest 
that under inflammatory conditions, SDF-1 could promote 
skin infiltration of Lin− CD123+ CD127low cells.
FigUre 5 | steady-state peripheral lin− cd123+ cd127+ population expresses limited T helper type cytokine variety. Percentages of positive and 
negative cells that express IFN-γ, IL-2, and IL-4; IL-17 and IL-22 in the presence of PMA/Iono (6 h) (a) Lin− CD123+ and Lin− CD127+ (B) populations within 
peripheral blood mononuclear cells. (c,d) IFN-γ expression in Lin− CD123+ and Lin− CD127 after 18 h of activation with the ILC1 cocktail (IL-12 + IL-15). In each 
panel, FMO controls are shown in the upper panels. Density plots are representative of at least three independent experiments. FMO, fluorescence minus one 
control.
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The lin− cd123+ cd127low Population 
within the lymphoid region 
downregulates cd123 and Basophil 
Markers upon activation
The majority of Lin− CD123+ CD127low cells within the lymphoid 
region downregulates CD123 and basophil markers such as FcεR, 
CCR3, and CD203c upon activation. In contrast, most CD123+ 
FSCint SSCint counterparts maintain the expression of these mol-
ecules (Figures 8A–C).
Considering that a reduction of the antigen recognized by 
2D7 has been reported in activated basophils, the expression 
of IL-8 and 2D7 was evaluated after activation with PMA/
Ionomycin and by IgE crosslinking. Remarkably, the population 
expressing IL-8 is the CD123lowand not the one maintaining 
high expression of CD123. We did not observe IL-8 expression 
after IgE crosslinking. In contrast, both cell populations reduced 
the expression of 2D7 in response to PMA/Ionomycin and IgE 
(Figure  8D). These results clearly show important functional 
differences between the lymphoid Lin− CD123+ CD127low 
population and the CD123+ FSCint SSCint one, suggesting that 
the Lin− CD123+ CD127low population from the lymphoid region 
may require activation to acquire ILC functional features and to 
diminish basophil activity.
Barrier Tissues, such as skin, are 
normally infiltrated by a specialized lin− 
cd123low cd127int Population with ilc 
Features
Considering the high expression of CLA in the Lin− CD123+ 
CD127low population and the downregulation of CD123 after 
activation next, we investigated whether an equivalent CD123+ 
population might be identified in the skin. We found Lin− 
CD123low and Lin− CD127+ cells in the dermis of CS (Figure 9A). 
Notably, in the skin, the Lin− CD123low population exhibited an 
increased expression of CD127 and CD90 compared with the PB 
CD123+ CD127low population; however, it expressed lower levels 
of CD132 and CD161. The Lin− CD123low population in skin is 
positive for c-Kit, CRTH2, AhR, and IL-23 and expresses high 
FigUre 6 | The lin− cd123+ cd127low population in PB expresses high 
levels of il-8. (a) IL-8 and IL-4 quantification in culture supernatants from 
isolated Lin− CD123+ cells (within the lymphoid region gated as depicted in 
Figure S1A in Supplementary Material) cultured for 18 h ± IL-3, PMA/Iono or 
IL-3 + PMA/Iono. (B) Percentages of positive and negative cells that express 
IL-8 (lower panel) in the presence of PMA/Iono (6 h) in Lin− CD123+ and 
Lin− CD127+ populations within peripheral blood mononuclear cells (PBMCs). 
Upper panel: FMO control for each cell population. Dot plots are 
representative of at least three independent experiments. (c) Percentage of 
Lin− CD123+ and Lin− CD127+ IL-8+ cells within PBMCs ± IL-3 and PMA/
Iono (n = 5). (d) Expression of IFN-γ, IL-2, IL-4, and IL-8 in sorted (as in 
Figure 1) in Lin− CD123+ cultured in the presence of PMA/Iono for 6 h. 
Density plots are representative of at least three independent experiments. 
FMO, fluorescence minus one control (**p < 0.01).
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levels of NKp44 compared with the CD127+ population. Although 
similar levels of CLA and CXCR4 are recorded (Figure 9B), the 
Lin− CD123low population does not express basophil markers 
such as FcεR, CCR3, CD203c, or 2D7 (Figure 9C). Surprisingly, 
among the Lin− CD123low population in the CS, ILC1, ILC2, 
and ILC3 (NKP44+ and NKP44−) may be identified by pheno-
type (Figure  9D). Among the CD127+ ILC population, ILC1, 
ILC2, and ILC3 (NKp44+ and NKp44−) were also identified 
(Figure 9E). However, the proportions are different compared 
with the Lin− CD123low skin population and the PB CD127+ 
ILC, as well as between different CS samples (data not shown). 
Considering that the Th cytokine production by ILC has mainly 
been reported in peripheral tissues, the cytokine production by 
the CS Lin− CD123low population was subsequently evaluated. 
After activation, the Lin− CD123low population present in CS 
expresses IFN-γ, IL-2, and IL-4 and, remarkably, IL-17 and IL-22 
(Figure 10A). The CD127+ ILC population exhibited a similar 
pattern of cytokine expression; however, the percentages were 
different between both populations (Figure 10B) and between 
different CS biopsies. As a result of the expression of IL-17 
and IL-22 after PMA/Ionomycin activation, we subsequently 
assessed whether the Lin− CD123low population responded to the 
ILC3 cocktail (IL-1β, IL-2, and IL-23) in CS. CS was stimulated 
with the ILC3 cocktail, PMA/Ionomycin or the combination. 
Figure 10C indicates that the Lin− CD123low population exhibits 
a minor expression of IL-22 or IL-17 in response to the ILC3 
cocktail; however, increases in the percentages of IL-22+, IL-17+, 
and both were identified in response to the combination of 
ILC3 cocktail and PMA/Ionomycin compared with only PMA/
Ionomycin. The expression of IL-17 by the skin Lin− CD123low 
cells and the CD127+ populations correlates with the expres-
sion of RORγt (Figure S6 in Supplementary Material) and with 
the ILC3 subset phenotype. Regarding the IL-8 expression, we 
determined that after stimulation, the Lin− CD123low popula-
tion from CS expressed IL-8 to a lesser extent compared with 
the PB Lin− CD123+ CD127low population (Figure 10A). These 
findings indicate that in accordance with the high expression 
of CLA in the Lin− CD123+ CD127low population from PB and 
with the downregulation of CD123 after activation, we identi-
fied a Lin− CD123low population in CS that exhibit increased 
phenotypic and Th type cytokine diversity compared with its 
PB counterpart. These findings strongly suggest that specialized 
Lin− CD123low CD127int population with ILC features normally 
infiltrate barrier tissues, such as skin, which appear to be in a late 
stage of activation.
sdF-1 dependent Migration of lin− 
cd123+ cd127low May Precede activation 
and local Production of il-17 and il-22 in 
Psoriasis Patients
As a result of the migratory potential and the ability of the Lin− 
CD123low CD127int population present in CS to express IL-17 
and IL-22, the frequencies and the expression of these cytokines 
by the ILC-related populations from psoriasis patients were 
subsequently assessed. Importantly, a significant increase in the 
frequencies of the Lin− CD123low CD127int population was identi-
fied in the skin lesions of psoriasis patients compared with the CS. 
Interestingly, an increase was also identified in the non-lesioned 
(NL) skin of psoriasis patients. We also identified an increase 
in the CD127+ population in the NL and lesioned skin from 
psoriasis patients (Figure 11A). The Lin− CD123low population in 
the CS expressed IL-17 and IL-22 only after activation. However, 
in some patients, the Lin− CD123low CD127int population from 
the lesioned and NL skin expressed IL-17 and IL-22, even in the 
absence of additional stimulation (Figure 11B). The expression of 
IL-17 was significantly increased in the skin lesions of the psoria-
sis patients both in the absence of additional stimulation and after 
stimulation compared with the unstimulated CS (Figure 11C). 
FigUre 7 | The lin− cd123+ cd127low cla+ population has migratory potential mediated by sdF-1. (a) CXCR4 (N = 6), CD62L (N = 5), and CCR6 (N = 6) 
expression in Lin− CD123+ and Lin− CD127+ cells from PB of healthy donors; bar graph representation of median fluorescence intensity values (n = 6). (B) Migration 
assay of Lin− CD123+ [from total peripheral blood mononuclear cells (PBMCs)] in the presence of SDF-1. (c) Amount of SDF-1, quantified by ELISA, in supernatants 
from control skin (CS) or psoriasis skin (PS) cell cultures. (d) Migration assay of Lin− CD123+ cells (from total PBMCs) in the presence of supernatants from CS or PS 
cell cultures ± blocking anti-CXCR4. (e) Transmigration assay of Lin− CD123+ cells (from total PBMCs) in the presence of activated endothelial cells and SDF-1 
(N = 10). Dot plots on the left indicate the percentage of Lin− CD123+ migrating cells and are representative of at least three independent experiments (*p < 0.05, 
**p < 0.01, ***p < 0.001).
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The expression of IL-22 in the psoriasis patients was significantly 
increased after stimulation compared with the non-stimulated 
CS (Figure  11D). The percentage of cells that expressed IL-22 
and notably IL-17 was increased in the Lin− CD123low popula-
tion compared with the CD127+ population (Figures  11C,D). 
These findings strongly suggest that SDF-1-dependent migration 
FigUre 8 | The lin− cd123+ cd127low population from the lymphoid 
region after activation downregulates cd123 and basophil markers. 
(a) Prospective identification of two CD123+ cell populations in the FSCint 
SSCint and FSClow SSClow fractions as FSCint SSCint (1) and FSClow SSClow (2) 
after activation with PMA/Iono (6 h). (B,c) Basophil markers expression after 
PMA/Iono (6 h) stimulation in the Lin− CD123+ (FSCint SSCint) and Lin− CD123+ 
(FSClow SSClow). Red: non-stimulated and orange: stimulated Lin− CD123+ (1: 
FSCint SSCint). Dark blue: non-stimulated and light blue: stimulated 
Lin− CD123+ (2: FSClow SSClow). White: isotype. Median fluorescence intensity 
values representative of three independent experiments are presented. (d) 
2D7 and IL-8 expression after PMA/Iono (6 h) stimulation or IgE crosslinking. 
Upper panel: Lin− CD123+ (FSCint SSCint) and lower panel: Lin− CD123+ 
(FSClow SSClow). FMO: for each population is shown at the right of each panel. 
Density plots are representative of at least three independent experiments. 
FMO, fluorescence minus one control.
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of Lin− CD123+ CD127low cells may precede the activation the 
downregulation of Lin− CD123 and local production of IL-22 and 
remarkably IL-17 in psoriasis patients.
discUssiOn
In the past years, a high diversity of ILC, including non-classical 
populations, has been described. Here, we report a Lin− CD123+ 
CD127low population in PB that possesses ILC features. Moreover, 
IL-3 appears to be crucial for its maintenance and identity. The 
Lin− CD123+ CD127low population highly expresses CLA and has 
skin-homing potential. Moreover, a similar population CD123low 
was identified in the skin, which likely participates in the patho-
genesis hallmarks of psoriasis.
Recently, different transcription factors have been described as 
crucial for ILC identity and development. NFIL3, which is regu-
lated by IL-7, is crucial for ILC development (16, 19). Classic ILC 
express IL-7Rα (CD127), although CD123 (IL-3Rα) is usually 
used to exclude basophils during ILC identification; this report 
identified a Lin− CD123+ CD127low population that expresses 
basophil and lymphoid markers but remarkably expresses several 
ILC features, which appears to be regulated by IL-3.
Classic ILC express CD127 however; recently, it has been 
reported the presence of non-classical CD127− ILC populations 
and also an early ILC precursor (EILP) CD127low (8, 9). The Lin− 
CD123+ population we report here shows lymphoid morphology 
and expresses low levels of CD127. However, to explore the 
lymphoid origin of such population, we evaluated unproductive 
DJ rearrangements as a molecular fingerprint of early lymphoid 
progenitors. There were no apparent rearrangements neither 
in the CD127+ classical ILC nor in the Lin− CD123+ CD127low 
population when compared with B-lymphocytes or in the acute 
B cell leukemia cell line NAL-M6. Nevertheless, the human ILC 
progenitor has only been described in tissues (46) and not in bone 
marrow or PB. Therefore, until now, the molecular features of the 
human ILC precursor are unknown. As an alternative to deter-
mine the lymphoid origin, the expression of CD7 was evaluated. 
Importantly, the Lin− CD123+ CD127low population expressed 
CD7, which has been reported to be expressed in the CLP and 
maintained in different lymphoid populations (3). Co-expression 
of CD127 and CD7 in the Lin− CD123+ population suggests 
lymphoid-related features. However, future studies are necessary 
to formally prove the lymphoid origin of this population.
CD123 is normally used to exclude pDCs, basophils, and mast 
cells when identifying ILC. However, the Lin− CD123+ CD127low 
population showed clear differences in the expression of MHC-II, 
BDCA-4, and BDCA-2 compared to pDCs. With regard to mast 
cell similarities, the low abundance of mast cells in PB under 
normal conditions suggest that the CD123+ CD127low population 
are not mast cells or their precursors, as they did not expressed 
CD34 (35). Nevertheless, in this report, we identified a mixture 
of lymphocyte-sized cells with no segmented nuclei (no lobes) 
and cells with classical basophil morphology (lobed nuclei). In 
addition, two populations of Lin− CD123+ cells were observed, 
the Lin− CD123+ CD127low population from the lymphoid region 
(FSClow/SSClow) and an FSCint SSCint CD123+ population. The 
Lin− CD123+ CD127low CD7low population from the lymphoid 
region expresses similar levels of the basophil markers FcεR and 
CCR3, compared to the CD123+ FSCint SSCint region. However, it 
expresses lower levels of CD203c and of the antigen recognized 
by mAb 2D7, which is expressed in basophil granules, indicat-
ing the expression of less granules in this population (43). Our 
results show then, a distinct Lin− CD123+ CD127low population 
within the lymphoid region with ILC properties that transiently 
share some features with CD123+ basophils from the FSCint SSCint 
region. Importantly, such population decreases the expression of 
basophil markers upon activation, whereas most CD123+ cells 
from the FSCint SSCint region maintains the expression of CD123 
and show more stable basophil marker display after activation. 
Of special interest for our future investigations, subfractioning 
the two subsets described in this study will be highly relevant 
FigUre 9 | Barrier tissues, such as skin, are normally infiltrated by specialized lin− cd123low cd127int with innate lymphoid cell (ilc) features. Total 
skin cells from the epidermis of control skin (CS) were analyzed as in peripheral blood. (a) From left to right: gate analysis on lymphoid cells, exclusion of lineage 
positive cells (CD3+, CD14+, CD19+, CD94+, HLA-DR+), and identification of Lin- cells: Lin− CD123low and Lin− CD127+ populations. (B) Compared expression of 
multiple ILC markers in the Lin− CD123low CD127+ and Lin− CD127+ populations. (c) Basophil markers expression in the Lin− CD123low from CS. Black:  
Lin− CD123low, gray: Lin− CD127+, and white: isotype. Median fluorescence intensity values representative of three independent experiments are presented.  
(d,e) Classification of skin ILC subpopulations: gated on: CD161+ cells; ILC1 (CRTH2−, c-Kit−), ILC2 (CRTH2+), and ILC3 (CRTH2−, c-Kit+) subpopulations within the 
Lin− CD123low (d) and Lin− CD127+ (e) populations. Density plots and histograms are representative of at least three independent experiments.
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for further transcriptional analyses at the clonal level. Whether 
basophils and the Lin− CD123+ CD127low population develop 
from a common progenitor, or their shared phenotypic proper-
ties only resemble the phenomenon referred to as lineage priming 
where “promiscuous expression of several lineage-affiliated genes 
precedes lineage commitment but does not alter the biological 
potential” as described for some oligo- or bipotential precursors 
(47), is still a matter in question.
Remarkably, in this report, several evidences support the find-
ing that the Lin− CD123+ CD127low from the lymphoid region 
population possesses several ILC features. First, the expression of 
low levels of CD127 by protein and mRNA. Second, the observed 
expression of CD7, which is related to CLP and maintained in 
different lymphoid cells, including the classical ILC. Third, the 
high expression of CD132, which has been reported as crucial 
for ILC development (48). Fourth, the expression of CD90, a 
classical ILC marker as well as other ILC markers such as CD161, 
α4 integrin which has been described in ILC precursors, and the 
expression of c-Kit, CRTH2, AhR, IL-23R, and CCR6. Fifth, the 
expression of several transcription factors such as Id2, NFIL3, 
TOX, PLZF described for ILC identification in humans (16, 
17, 34) and TCF-1, recently described for ILC development in 
mice (15, 49), and sixth, the increase in NFIL3, TOX, and PZLF 
expression by IL-3 suggesting that NFIL3 might regulate the 
identity of the ILC-related features in the Lin− CD123+ CD127low 
population. Thus, our data indicate that the use of anti-FcεR and 
anti-CD123 in the linage cocktail in previous reports may have 
limited the identification of an alternative population with ILC 
features in PB.
In human PB, classical ILC express CD161 and exhibit phe-
notypic diversity (ILC1, ILC2, and ILC3 NKp44−). Interestingly, 
the PB Lin− CD123+ CD127low population comprises a majority 
conspicuous population (CD161low, c-Kit+, and CRTH2+), which, 
by phenotype, is similar to ILC2 and a minority of ILC1 and ILC3 
populations. This finding was inconsistent with the low expres-
sion of GATA-3 and the expression of T-bet and RORγt. GATA-3 
has been reported as crucial for classical ILC development (50, 
51). Moreover, it has recently been reported that a common ILC 
progenitor RORγt+ present in secondary lymphoid tissue has the 
potential in vitro to give rise to all human ILC subpopulations 
(46). These findings support the idea that the expression of RORγt 
in the Lin− CD123+ CD127low population in PB may be related to a 
further process of differentiation and diversification of this popu-
lation in peripheral tissues. In contrast, in the classical CD127+ 
ILC population in PB, similar to other reports (39–41), ILC1, 2, 
and 3, as well as the expression of T-bet, RORγt, and GATA-3, 
FigUre 10 | skin lin− cd123low cells produce il-17 and il-22. (a,B) Percentages of positive and negative total skin cells that express IFN-γ, IL-2, IL-4; IL-17, 
IL-22, and IL-8 in the presence of PMA/Iono (6 h) in the Lin− CD123low (a) and Lin− CD127+ (B) populations within total control skin cells. Upper panels: FMO 
controls. (c) Expression of IL-17 and IL-22 in the Lin− CD123low skin cells cultured for 18 h in the presence of IL-1β, IL-2, and IL-23 (ILC3 activation cocktail) ± PMA/
Iono (last 6 h) or ILC3 activation cocktail + PMA/Iono (last 6 h). Density plots are representative of at least three independent experiments. FMO, fluorescence minus 
one control.
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were identified. These findings indicate that both populations 
share several ILC features; however, the Lin− CD123+ CD127low 
population in PB may be in a different stage of differentiation 
and it may require different transcriptional factors and cytokines 
for development.
It has been reported that ILC express cytokines similar to 
the Th lymphocytes in peripheral tissues (4, 52). However, 
there are few reports in PB and most of the studies use cell lines 
derived from ILC obtained from patients (7, 39, 40). The freshly 
isolated Lin− CD123+ CD127low population expresses only IL-4 
after activation and the classical CD127+ population expresses 
IL-2 (data not shown). However, among the total PBMCs, the 
Lin− CD123+ CD127low and the classic CD127+ ILC populations 
expressed IFN-γ in response to PMA/Ionomycin and the ILC1 
activation cocktail. However, even in the presence of IL-1β, IL-2, 
and IL-23, the Lin− CD123+ CD127low and CD127+ ILC did not 
express IL-17 or IL-22, which indicates that steady-state PB 
ILC populations may require further differentiation or activa-
tion to express all Th type varieties of cytokines. Importantly, 
the Lin− CD123+ CD127low population highly expresses IL-8 
compared with the classical CD127+ ILC, notwithstanding 
that IL-8 expression by ILC has only been assessed in a limited 
number of reports (6, 53), and the function of this cytokine 
expression in PB ILC has not been investigated. Interestingly, 
the population that expresses cytokines after activation shows a 
downregulation of CD123, therefore further examination of the 
phenotype and function of the Lin− CD123+ CD127low popula-
tion after activation was evaluated. Interestingly, the population 
downregulating CD123 expresses IL-8 and decreases the expres-
sion of basophil markers, including 2D7. Of note, these effects 
were not observed in the population that maintains the CD123 
expression or after IgE croslinking. However, upon IgE activa-
tion, an important decrease in the 2D7 expression was observed 
in the Lin− CD123+ CD127low population, suggesting the activity 
of this population in response to IgE. These results suggest that 
activation of the Lin− CD123+ CD127low cells may precede their 
capability of acquiring ILC function and diminishes basophil 
activity.
In mouse models, it has been proposed that the complete 
differentiation of ILC occurs in peripheral tissues (15, 49). In 
human tonsils, the identification of an ILC3 subpopulation that 
presents a “naïve” phenotype has been recently described; these 
cells were unresponsive to IL-23 and IL-1β, despite their expres-
sion of IL23R and IL1R1 transcripts, and were characterized 
FigUre 11 | sdF-1-dependent migration of lin− cd123low cd127low cells may precede activation and local production of il-17 and il-22 in psoriasis 
patients. (a) Frequencies of Lin− CD123low and Lin− CD127+ populations in control skin (CS) N = 7, non-lesioned (NL) skin N = 7, and lesioned (L) N = 15 skin from 
psoriasis patients. (B) Intracellular expression of IL-17 and IL-22 in Lin− CD123low cells from CS, NL and L skin cultured during 18 h ± IL-1β, IL-2, and IL-23 (ILC3 
activation cocktail) ± PMA/Iono (last 6 h) Dot plots are representative of at least three independent experiments. FMO, fluorescence minus one control. (c,d) 
Percentages of skin IL-17+ and IL-22+ Lin− CD123low cells (CS: N = 7 and L: N = 12) or Lin− CD127+ cells (CS: N = 4 and L: N = 11) cultured during 18 h ± IL-2, 
IL-23, and IL-1β (ILC3 activation cocktail) + PMA/Iono (*p < 0.05, **p < 0.01).
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by the expression of CD62L and CD45RA (23). Our findings 
demonstrated that the Lin− CD123+ CD127low population in PB 
has limited Th cytokine production and highly expresses homing 
molecules (CLA, CXCR4, and CD62L) and also a IL23R and 
AhR, which, in addition to the expression of RORγt, suggests that 
this population may be in an early stage of differentiation with the 
potential to migrate into different tissues to be fully differentiated.
Importantly, an equivalent of the CD123+ population was 
present in the CS that expresses several ILC features (CD127int, 
CD132, CD90, c-Kit, CRTH2, AhR, IL-23R, NKp44, and CCR6), 
where an increased phenotypic diversity (ILC1, ILC2, and 
ILC3) was also identified. Consistent with this diversity, more 
Th type cytokines, including IL-22 and remarkably IL-17, were 
identified in the skin Lin− CD123+ population after activation. 
FigUre 12 | a human lin− cd123+ cd127low endowed with innate 
lymphoid cells (ilc) features and migratory capabilities contributes to 
immunopathological hallmarks of psoriasis. Peripheral blood (PB) 
contains a Lin− CD123+ population with a mixture lymphoid (in red: CD127low 
CD7low) and basophil markers expression (in purple: FcεR, CCR3, CD203int 
2D7low) and is endowed with high migratory capabilities [cutaneous 
lymphocyte antigen (CLA) and CXCR4]. In steady state, this population 
possesses several ILC features (in blue: Lin−, CD132+, CD90+, CD161+, 
NFIL-3+, TCF-1+, Id2+, TOX+, PLZF+) and after activation with IL-3 increase 
this features. This population after PMA/Iono treatment downregulates 
CD123, is able to produce IL-8, IL-4, and IL-2, and diminish the basophil 
markers. A similar but specialized CD123low population normally infiltrates 
barrier tissues, such as skin. We propose that CXCR4-SDF-1 is an important 
skin-homing mechanism under inflammatory conditions, particularly in 
psoriasis. The increase of the CD123low population in the non-lesioned and 
lesioned skin of psoriasis patients supports its high migratory potential. 
Remarkably, the expression of IL-22 and particularly IL-17 by the CD123low 
population in the skin of psoriasis patients strongly suggests that this 
population may contribute to the immunopathological hallmarks of a skin 
disease such as psoriasis.
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The expression of IL-22 and IL-17 was consistent with the 
high expression of IL-23 and AhR (54) in the Lin− CD123low 
population. This finding suggests that in peripheral tissues, this 
population may express a wider variety of cytokines as reported 
for other ILC subsets (24, 28). These findings also support that in 
the skin, the CD123+ population becomes fully differentiated, as 
proposed in the mouse model for the classical ILC subsets (15, 
55). The cytokine expression by the direct isolated skin ILC was 
not evaluated; therefore, it is possible that other activated cells in 
the skin cultures may contribute to the cytokine expression by the 
Lin− CD123low CD127int population, like has been described for 
ILC2 in skin (56). Remarkably, the Lin− CD123low population in 
skin expresses IL-8, which may be relevant in the recruitment of 
other innate cells, such as neutrophils (57). Similar to the PB, the 
CD123+ population in the skin is more frequent than the classi-
cal CD127+ ILC. Therefore, it is possible that the high expression 
of CLA may be involved in non-inflammatory skin homing as 
reported for T cells (58) and ILC, in which CLA expression in 
ILC2 and ILC3 is sufficient to identify cells with potential to 
migrate into the skin (39, 40). Our findings suggest that the 
Lin− CD123+ CD127low CLA+ population identified in PB may 
represent a steady-state reservoir with the potential to migrate 
into the skin, mediated by CLA, and suggest that barrier tissues, 
such as skin, are normally infiltrated by specialized Lin− CD123low 
CD127int populations with ILC-related features.
In addition, we demonstrated that the Lin− CD123+ CD127low 
population transmigrates in response to SDF-1 and in the pres-
ence of activated endothelial cells mediated by SDF-1. Similar to 
other reports (59, 60) and other inflammatory diseases (61), an 
increase in the levels of SDF-1 in the supernatants of psoriasis 
patients was identified; this finding suggests that the CXCR4/SDF-
1-dependent migration is an additional migration mechanism, 
which may be relevant during inflammatory conditions, such as 
psoriasis. A CCR10–CCL27 interaction has been proposed as a 
mechanism for homeostatic skin migration. However, in mouse 
models of inflammation, a decrease in the number of CCR10+ 
ILC in the skin has been reported (62), in addition to a decreased 
expression of CCL27 in psoriasis (63). In this report, we propose 
that CXCR4-SDF-1 is an alternative mechanism in psoriasis (and 
inflammatory conditions), which may explain the presence of 
ILC and cytokine production in psoriasis patients even in the 
absence of CCL27.
Importantly, both the Lin− CD123low and CD127+ populations 
were increased in the skin of psoriasis patients; however, it is 
possible that the CD127+ ILC may migrate by a mechanism inde-
pendent of CXCR4/SDF-1 but CCR6-dependent because high 
levels of CCR6 were identified in the CD127+ ILC population. 
Remarkably, both populations express IL-22 and IL-17 in the skin 
of psoriasis patients and represent two hallmark cytokines in the 
immunopathology of psoriasis in mouse models and humans 
(64–66). The expression of these cytokines was increased in the 
Lin− CD123low population compared with the CD127+ ILC. It has 
been reported that a CD3− population expresses IL-17 in the PB 
and skin of psoriasis patients (41). However, there is only one 
report of a slight production of IL-17 by classic NCR+ ILC3 from 
the skin of psoriasis patients (40). Our findings indicate that the 
Lin− CD123low population may be an important and additional 
innate source of IL-22 and, importantly, IL-17 in the lesioned 
and probably in the NL skin of psoriasis patients. In addition, 
our findings suggest that the SDF-1-dependent migration of Lin− 
CD123+ CD127low cells from the PB to the skin may precede the 
activation and local production of IL-17 and IL-22 in psoriasis 
patients.
In summary, according to the proposed model (Figure 12), 
we have identified in PB a novel Lin− CD123+ CD127low popula-
tion with a mixture of lymphoid (CD127low CD7low) and basophil 
(FcεR, CCR3, CD203int 2D7low) properties that possesses several 
ILC features, including the phenotype Id2+ NFIL3+ PLZF+ 
TOX+ TCF-1+ CD132+ CD90+ CD161+α4 integrin+ c-Kit+ 
CRTH2+AhR+IL-23R+ CCR6+, and high migratory capabilities. 
IL-3 appears to comprise a crucial growth factor for survival of 
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the ILC-related features in the Lin− CD123+ CD127low population. 
A similar but specialized Lin− CD123low population normally 
infiltrates barrier tissues, such as skin. We propose that CXCR4/
SDF-1 is an important skin-homing mechanism under inflam-
matory conditions in psoriasis. The increase of the Lin− CD123low 
population in the NL and lesioned skin of psoriasis patients 
supports its high migratory potential. Remarkably, expression of 
IL-22 and particularly IL-17 by the Lin− CD123low population in 
the skin of psoriasis patients strongly suggests that this popula-
tion may contribute to the immunopathological hallmarks of a 
skin disease such as psoriasis.
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